Receive monthly emails about the latest oncology research and technology, new patient services, resources and more!

Please select an option below to help us tailor your newsletter to best suit your content interests!

No thanks

Trust your cancer care to our providers at West Cancer Center & Research Institute who authored 119 publications in distinguished medical journals in 2020 alone. We are standing behind our name and respected by leaders in oncology care.

  1. Matthew Ballo:
    • VanderWalde NA, Martin MY, Kocak M, Morningstar C, Deal AM, Nyrop KA, Farmer M, Ballo M, VanderWalde A, Muss H. Randomized phase II study of a home-based walking intervention for radiation-related fatigue among older adult breast cancer patients. J Geriatr Oncol. 2020 Sep 22:S1879-4068(20)30440-9. doi: 10.1016/j.jgo.2020.09.013. Epub ahead of print. PMID: 32978102.
    • Lacouture ME, Anadkat MJ, Ballo MT, Iwamoto F, Jeyapalan SA, La Rocca RV, Schwartz M, Serventi JN, Glas M. Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma. Front Oncol. 2020 Jul 28;10:1045. doi: 10.3389/fonc.2020.01045. PMID: 32850308; PMCID: PMC7399624.
  2. *Michael Berry:
    • Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Garber JE, Goggins M, Hutton ML, Khan S, Klein C, Kohlmann W, Kurian AW, Laronga C, Litton JK, Mak JS, Menendez CS, Merajver SD, Norquist BS, Offit K, Pal T, Pederson HJ, Reiser G, Shannon KM, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Dwyer MA, Darlow SD. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020. J Natl Compr Canc Netw. 2020 Apr;18(4):380-391. doi: 10.6004/jnccn.2020.0017. PMID: 32259785.
    • Jain AL, Mullins J, Smith JR, Valasareddy P, Miller E, Chaudhry A, Ryder J, Hare F, Ranganath H, Berry M, Robins D, Schwartzberg L, Vidal GA. Unusual recurrent metastasizing benign breast papilloma: a case report. J Med Case Rep. 2020 Feb 19;14(1):33. doi: 10.1186/s13256-020-2354-7. PMID: 32070435; PMCID: PMC7029571.
  3. Jason Chandler:
    • Kumar SK, Callander NS, Adekola K, Anderson L, Baljevic M, Campagnaro E, Castillo JJ, Chandler JC, Costello C, Efebera Y, Faiman M, Garfall A, Godby K, Hillengass J, Holmberg L, Htut M, Huff CA, Kang Y, Hultcrantz M, Larson S, Liedtke M, Martin T, Omel J, Shain K, Sborov D, Stockerl-Goldstein K, Weber D, Keller J, Kumar R. Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Dec 2;18(12):1685-1717. doi: 10.6004/jnccn.2020.0057. PMID: 33285522.
    • Waterhouse DM, Garon EB, Chandler J, McCleod M, Hussein M, Jotte R, Horn L, Daniel DB, Keogh G, Creelan B, Einhorn LH, Baker J, Kasbari S, Nikolinakos P, Babu S, Couture F, Leighl NB, Reynolds C, Blumenschein G Jr, Gunuganti V, Li A, Aanur N, Spigel DR. Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153. J Clin Oncol. 2020 Nov 20;38(33):3863-3873. doi: 10.1200/JCO.20.00131. Epub 2020 Sep 10. PMID: 32910710; PMCID: PMC7676888.
  4. Adam ElNaggar:
    • VanderWalde, A. Grothey, D. Vaena, G. Vidal, A.C. ElNaggar, G. Bufalino, L. Schwartzberg. Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting. J. Pers. Med. 2020, 10(4), 252. doi: 10.3390/jpm10040252. PMID: 33260805
    • Oaknin, A., C. F. Friedman, L. D. Roman, A. D’Souza, I. Brana, F. Clement-Bidard, J. Goldman, E. A. Alvarez, V. Boni, C. ElNaggar, R. Passalacqua, K. T. M. Do, A. D. Santin, K. Keyvanjah, F. Xu, L. D. Eli, A. S. Lalani, R. P. Bryce, D. M. Hyman, F. Meric-Bernstam, D. B. Solit and B. J. Monk (2020). “Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial.” Gynecol Oncol. doi:10.1016/j.ygyno.2020.07.025. PMID: 32723675
    • Ulm, T. Redfern, B. Wilson, S. Ponnusamy, S. Asemota, P. Blackburn, Y. Wang, A.C. ElNaggar, R. Narayanan. Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer. J. Pers. Med. 2020, 10(4), 246. doi.org/10.3390/jpm10040246. PMID: 33256002
  5. Michael Farmer:
    • VanderWalde NA, Martin MY, Kocak M, Morningstar C, Deal AM, Nyrop KA, Farmer M, Ballo M, VanderWalde A, Muss H. Randomized phase II study of a home-based walking intervention for radiation-related fatigue among older adult breast cancer patients. J Geriatr Oncol. 2020 Sep 22:S1879-4068(20)30440-9. doi: 10.1016/j.jgo.2020.09.013. Epub ahead of print. PMID: 32978102.
  6. Axel Grothey:
  7. Clay Jackson:
    • Jackson WC. Connecting the dots:  how adverse childhood experiences predispose to chronic pain. Practical Pain Management 2020;20(3):24-28.. 
    • Trivedi MH, Papakostas GI, Jackson WC, Rafeyan R. Implementing measurement-based care to determine and treat inadequate respo J Clin Psychiatry. 2020 May 5;81(3):OT19037BR1. doi: 10.4088/JCP.OT19037BR1.PMID: 32369683. 
    • Rafayen R, Papakostas GI, Jackson WC, Trivedi MH. Inadequate response to treatment in major depressive disorder:  augmentation and adjunctive strategies J Clin Psychiatr 2020 May 19;81(3):OT19037COM5. doi: 10.4088/JCP.OT19037COM5.PMID: 32433833
    • Papakostas GI, Jackson WC, Rafeyan R, Trivedi MH. Overcoming challenges to treat inadequate response in major depressive disorder. J Clin Psychiatry. 2020 May 12;81(3):OT19037BR4. doi: 10.4088/JCP.OT19037BR4.
    • Jackson WC, Papakostas GI, Rafeyan R, Trivedi MH. Recognizing inadequate response in patients with major depressive disorder. J Clin Psychiatry. 2020 May 5;81(3):OT19037BR2. doi: 10.4088/JCP.OT19037BR2.PMID: 32369684
  8. Robert Johnson:
    • Otieno SB, Nasir S, Weir A, Johnson R. Rapid Response in a Patient with Relapsed/Refractory Multiple Myeloma Treated with BRAF/MEK Inhibitors. Case Rep Hematol. 2020 Dec 11;2020:8821415. doi: 10.1155/2020/8821415. PMID: 33381330; PMCID: PMC7748897.
  9. Michael G. Martin:
    • Morris LK, Altahan A, Gandhi J, Mays J, Giri U, Fleming M, Martin MG. Impact of margin status on survival after radical nephrectomy for renal cell carcinoma. J Surg Oncol. 2020 Dec 17. doi: 10.1002/jso.26321. Epub ahead of print. PMID: 33333591.
    • Altahan A, Harris LJ, Porta J, Jain AL, Martin MG. Association Between Pesticide Use and Incidence of Diffuse Large B-Cell Lymphoma. Anticancer Res. 2020 Oct;40(10):5423-5426. doi: 10.21873/anticanres.14552. PMID: 32988863.
    • Adeniji AA, Dawodu OO, Habeebu MY, Oyekan AO, Bashir MA, Martin MG, Keshinro SO, Fagbenro GT. Distribution of Breast Cancer Subtypes Among Nigerian Women and Correlation to the Risk Factors and Clinicopathological Characteristics. World J Oncol. 2020 Aug;11(4):165-172. doi: 10.14740/wjon1303. Epub 2020 Aug 10. PMID: 32849957; PMCID: PMC7430856.
    • Dulal S, Paudel BD, Wood LA, Neupane P, Shah A, Acharya B, Shilpakar R, Acharya SC, Karn A, Poudel B, Thapa RR, Acharya A, Martin MG. Reliance on Self-Medication Increase Delays in Diagnosis and Management of GI Cancers: Results From Nepal. JCO Glob Oncol. 2020 Aug;6:1258-1263. doi: 10.1200/GO.20.00202. PMID: 32762562; PMCID: PMC7456311.
    • Dulal S, Adeniji AA, Martin MG. Feasibility of Fewer Fraction Palliative Radiotherapy in Resource-Limited Setting. World J Oncol. 2020 Apr;11(2):76-77. doi: 10.14740/wjon1271. Epub 2020 Mar 29. PMID: 32284776; PMCID: PMC7141159.
    • Stein MK, Williard FW, Xiu J, Tsao MW, Martin MG, Deschner BW, Dickson PV, Glazer ES, Yakoub D, Shibata D, Grothey AF, Philip PA, Hwang JJ, Shields AF, Marshall JL, Korn WM, Lenz HJ, Deneve JL. Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma. J Surg Oncol. 2020 Jun;121(8):1320-1328. doi: 10.1002/jso.25899. Epub 2020 Mar 12. PMID: 32166754; PMCID: PMC7505122.
    • Stein MK, Morris LK, Martin MG. Next-Generation Sequencing Identifies Novel RTK VUSs in Breast Cancer with an Emphasis on ROS1, ERBB4, ALK and NTRK3. Pathol Oncol Res. 2020 Jan;26(1):593-595. doi: 10.1007/s12253-018-0550-1. Epub 2018 Nov 20. PMID: 30460540.
  10. Sameer Nasir:
    • Otieno SB, Nasir S, Weir A, Johnson R. Rapid Response in a Patient with Relapsed/Refractory Multiple Myeloma Treated with BRAF/MEK Inhibitors. Case Rep Hematol. 2020 Dec 11;2020:8821415. doi: 10.1155/2020/8821415. PMID: 33381330; PMCID: PMC7748897.
    • Delgado-Ramos GM, Nasir SS, Wang J, Schwartzberg LS. Real-world evaluation of effectiveness and tolerance of chemotherapy for early-stage breast cancer in older women. Breast Cancer Res Treat. 2020 Jul;182(2):247-258. doi: 10.1007/s10549-020-05684-5. Epub 2020 May 23. PMID: 32447595.
  11. Arnel Pallera:
    • Deininger MW, Shah NP, Altman JK, Berman E, Bhatia R, Bhatnagar B, DeAngelo DJ, Gotlib J, Hobbs G, Maness L, Mead M, Metheny L, Mohan S, Moore JO, Naqvi K, Oehler V, Pallera AM, Patnaik M, Pratz K, Pusic I, Rose MG, Smith BD, Snyder DS, Sweet KL, Talpaz M, Thompson J, Yang DT, Gregory KM, Sundar H. Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Oct 1;18(10):1385-1415. doi: 10.6004/jnccn.2020.0047. PMID: 33022644.
  12. Manjari Pandey:
    • Nabors LB, Portnow J, Ahluwalia M, Baehring J, Brem H, Brem S, Butowski N, Campian JL, Clark SW, Fabiano AJ, Forsyth P, Hattangadi-Gluth J, Holdhoff M, Horbinski C, Junck L, Kaley T, Kumthekar P, Loeffler JS, Mrugala MM, Nagpal S, Pandey M, Parney I, Peters K, Puduvalli VK, Robins I, Rockhill J, Rusthoven C, Shonka N, Shrieve DC, Swinnen LJ, Weiss S, Wen PY, Willmarth NE, Bergman MA, Darlow SD. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Nov 2;18(11):1537-1570. doi: 10.6004/jnccn.2020.0052. PMID: 33152694.
    • Ou A, Sumrall A, Phuphanich S, Spetzler D, Gatalica Z, Xiu J, Michelhaugh S, Brenner A, Pandey M, Kesari S, Korn WM, Mittal S, Westin J, Heimberger AB. Primary CNS lymphoma commonly expresses immune response biomarkers. Neurooncol Adv. 2020 Jan-Dec;2(1):vdaa018. doi: 10.1093/noajnl/vdaa018. Epub 2020 Feb 19. PMID: 32201861; PMCID: PMC7067145.
  13. Jason Porter:
  14. Sylvia Richey:
    • McAneny B, Schwartzberg L, Koh W-J, Arrowsmith E, Fugaro A, Haydell T, Heskeeth PJ, Pudusseri A, Richey S, Zarwan C, Stein R. Supporting optimal, value-based, and sustainable cancer care delivery. J Clin Pathways 2020;6(8):58-61. doi:10.25270/jcp.2020.10.00002.
  15. David B. Robins:
    • Jain AL, Mullins J, Smith JR, Valasareddy P, Miller E, Chaudhry A, Ryder J, Hare F, Ranganath H, Berry M, Robins D, Schwartzberg L, Vidal GA. Unusual recurrent metastasizing benign breast papilloma: a case report. J Med Case Rep. 2020 Feb 19;14(1):33. doi: 10.1186/s13256-020-2354-7. PMID: 32070435; PMCID: PMC7029571.
  16. Alex Ryder:
    • Hauser RG, Kwon RJ, Ryder A, Cheng C, Charifa A, Tormey C. Transfusion Medicine Equations Made Internet Accessible. Transfus Med Rev. 2020 Jan;34(1):5-9. doi: 10.1016/j.tmrv.2019.10.003. Epub 2019 Nov 16. PMID: 31785949.
    • Nagel MB, Ryder A, Lobbins M, Bhatt N. Refractory acquired thrombotic thrombocytopenic purpura treated with caplacizumab in a pediatric patient with systemic lupus erythematosus. Pediatr Blood Cancer. 2021 Jan;68(1):e28534. doi: 10.1002/pbc.28534. Epub 2020 Jul 13. PMID: 32658352.
  17. Lee Schwartzberg:
  18. Courtney Shires:
    • Klug TD, Craig J, Shires CB. Awake ECMO without anticoagulation for nearly completely obstructive squamous cell carcinoma of the trachea. Clin Case Rep. 2020 Nov 6;9(1):164-168. doi: 10.1002/ccr3.3490. PMID: 33489153; PMCID: PMC7813012.
    • Klug T, Sebelik M, Shires CB. Chyloma formation after anterior cervical disc fusion. Clin Case Rep. 2020 Aug 26;8(12):2721-2724. doi: 10.1002/ccr3.3274. PMID: 33363812; PMCID: PMC7752606.
    • Shires CB, Klug T, Shete M, Sebelik M. Multiplanar Computed Tomography Reconstruction to Diagnose Lemierre’s Syndrome. OTO Open. 2020 Jul 8;4(3):2473974X20940692. doi: 10.1177/2473974X20940692. PMID: 32685872; PMCID: PMC7346694.
  19. *Bradley G. Somer:
  20. Todd Tillmanns:
    • Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Huh WK, Lurain Iii JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Urban R, Wyse E, McMillian NR, Motter AD. NCCN Guidelines Insights: Cervical Cancer, Version 1.2020. J Natl Compr Canc Netw. 2020 Jun;18(6):660-666. doi: 10.6004/jnccn.2020.0027. PMID: 32502976.
  21. Michael Ulm:
    • Ulm, T. Redfern, B. Wilson, S. Ponnusamy, S. Asemota, P. Blackburn, Y. Wang, A.C. ElNaggar, R. Narayanan. Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer. J. Pers. Med. 2020, 10(4), 246. doi.org/10.3390/jpm10040246. PMID: 33256002
  22. Daniel Vaena:
    • VanderWalde A, Grothey A, Vaena D, Vidal G, ElNaggar A, Bufalino G, Schwartzberg L. Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting. J Pers Med. 2020 Nov 27;10(4):252. doi: 10.3390/jpm10040252. PMID: 33260805; PMCID: PMC7711773.
    • Figlin RA, Tannir NM, Uzzo RG, Tykodi SS, Chen DYT, Master V, Kapoor A, Vaena D, Lowrance W, Bratslavsky G, DeBenedette M, Gamble A, Plachco A, Norris MS, Horvatinovich J, Tcherepanova IY, Nicolette CA, Wood CG; ADAPT study group. Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma. Clin Cancer Res. 2020 May 15;26(10):2327-2336. doi: 10.1158/1078-0432.CCR-19-2427. Epub 2020 Feb 7. PMID: 32034074.
    • Stein J, Milhem M, Vaena D. Clinical outcomes and toxicities of pazopanib administered orally in crushed form: Case reports and review of the literature. J Oncol Pharm Pract. 2020 Jan;26(1):232-235. doi: 10.1177/1078155219841108. Epub 2019 Apr 8. PMID: 30961437.
  23. Ari VanderWalde: https://www.ncbi.nlm.nih.gov/myncbi/1nS9yizO-lrAZ/bibliography/public/
  24. Noam VanderWalde: https://www.ncbi.nlm.nih.gov/myncbi/1PUcZ0u3y-tAo/bibliography/public/
  25. *Gregory Vidal:
X